1. Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy. Issue 5 (21st July 2022) Authors: Wei, Xiaohui; Naseer, Shabnam; Weinstein, Edward A.; Iarikov, Dmitri; Nambiar, Sumathi; Reynolds, Kellie S.; Jang, Seong H. Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 5(2022) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®). (2nd December 2020) Authors: Naseer, Shabnam; Weinstein, Edward A; Rubin, Daniel B; Suvarna, Kalavati; Wei, Xiaohui; Higgins, Karen; Goodwin, Avery; Jang, Seong H; Iarikov, Dmitri; Farley, John; Nambiar, Sumathi Journal: Clinical infectious diseases Issue: Volume 72:Number 12(2021) Page Start: e1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗